Skip to main content
Thursday
March 05, 2026
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Get the Paper
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Explainer
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
THURSDAY,
MARCH 05, 2026
Serum Institute of India
Serum Institute of India
Serum to export vaccine to Bangladesh by 25 Jan: Beximco
"Beximco has completed 75% of its preparation for vaccine management"
India ready for rollout of Covid-19 vaccines within 10 days
Serum is permitted to export vaccines to all countries: CEO Poonawalla
Serum CEO’s remark on vaccine export ban is personal, Momen says quoting Delhi
Not allowing the Chinese vaccine was the wrong decision: Prof Nazrul
Beximco Pharma’s share price falls after India bans vaccine export
UK clearance to Oxford vaccine paves way for Bangladesh
Serum Institute request for emergency use of Oxford vaccine to be considered today
India's Serum Institute expects approval for AstraZeneca vaccine in days
India's Serum Institute seeks emergency use nod for AstraZeneca's Covid-19 vaccine
Serum Institute CEO Adar Poonawalla named 1 of 6 ‘Asians of the year’
Serum Institute says its vaccine candidate Covishield safe and immunogenic
Serum Institute CEO sees AstraZeneca's vaccine as "very good" candidate
Show More